All articles by
ConTIPI Medical receives FDA approval for unique product to treat pelvic organ prolapse in women
The Company was founded in 2014 by Dr. Elan Ziv, founder and CEO of the Company, an expert in gynecology…
Endophys introduces new blood pressure monitoring device
Endophys has designed the new 8-French and 25cm access sheath to offer deeper access to the femoral artery and measure…
Neurolief gets CE mark for Relivion digital treatment for migraine
The CE mark enables the company to market, sell and distribute the Relivion device as an over-the-counter therapy within the…
Medeon led and completed investments in Panther Orthopedics and Prodeon
Panther Orthopedics is a Silicon Valley startup company pioneering innovative dynamic fixation solutions for orthopedic extremity applications. Prodeon is a…
Bruker buys preclinical and molecular imaging research software provider PMOD
PMOD offers research-use-only software for preclinical and molecular imaging, with a primary focus on molecular quantification and pharmacokinetic modelling. PMOD,…
Biotronik gets FDA nod for next-generation injectable cardiac monitor
Biomonitor III has been developed to determine suspected arrhythmia or unexplained syncope with increased clarity, facilitating quick diagnosis and appropriate…
NICE recommends electroCore’s gammaCore device to treat cluster headaches
The gammaCore is a handheld device that provides a small electric current for the prevention and treatment of cluster headaches.…
Isansys develops wireless monitoring technology for early sepsis detection
Isansys Lifecare has designed and developed Patient Status Engine wireless monitoring system to quickly detect the onset of sepsis in…
Advent Access gets CE mark for av-Guardian vascular access system
The CE mark approval allows the company to distribute av-Guardian vascular access system for the customers in the European Economic…
ACT Genomics opens next generation sequencing laboratory in Hong Kong
ACT Genomics offers optimal cancer treatment planning, cancer relapse and drug resistance monitoring, cancer risk assessment and immunotherapy evaluation to…